Privium Fund Management B.V. RARE Holdings History
Privium Fund Management B.V.'s Ultragenyx Pharmaceutical Inc Holding Summary
As of 2025-03-31, Privium Fund Management B.V. held 249,804.00 shares of Ultragenyx Pharmaceutical Inc(RARE), totaling $9.05 Mil. This investment constitutes 2.36% of their stock portfolio, and Privium Fund Management B.V. now holds 0.26% of the outstanding Ultragenyx Pharmaceutical Inc(RARE) stock.
The initial trade took place in 2021Q4. And since then Privium Fund Management B.V. has made 9 purchases of RARE, at an average price of $56.99, for a total of 297,856.00 shares. In addition, there have been 4 sales at an average price of $51.24 for 48,052.00 shares. Based on historical transaction data and RARE's current price of $28.04, Privium Fund Management B.V.'s estimated gain on his RARE holdings is $-7.51 Mil, reflecting a -44.24% gain to date.
Privium Fund Management B.V. RARE ($28.04) Holding Chart
Privium Fund Management B.V. RARE ($28.04) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1